Recruiting

Doxorubicin Hydrochloride Liposome in Treating Women With Ductal Carcinoma in Situ Undergoing Surgery

Sponsor:

Dr. Susan Love Research Foundation

Code:

NCT00671476

Conditions

Breast Cancer

Eligibility Criteria

Sex: Female

Age: 18+

Healthy Volunteers: Not accepted

Interventions

pegylated liposomal doxorubicin hydrochloride

DNA methylation analysis

TdT-mediated dUTP nick end labeling assay

fluorescence in situ hybridization

loss of heterozygosity analysis

Study Details

Eligibility Criteria

Study Design

Interventions and Outcome Measures

Central Contacts and Locations

More Information

Trial information was received from ClinicalTrials.gov and was last updated on 2025-03-28. This information was provided to ClinicalTrials.gov by Dr. Susan Love Research Foundation on 2014-01-10.